DTG-Based Regimen Comparable, But Not Superior, to EFV-400

(MedPage Today) -- Dolutegravir efficacy non-inferior to efavirenz-based regimen at week 48
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news